Castle Hill Hospital

The trials here

What the 19 trials at this site are about, from their registry records.

Conditions

• Childhood cancers4 trials
• Lung cancer3 trials
• Asthma2 trials
• Colorectal cancer2 trials
• Gastric and oesophageal cancer2 trials
• Heart failure2 trials
• Kidney cancer2 trials
• Cervical cancer1 trial
• Chronic lymphocytic leukaemia1 trial
• COPD1 trial
• Hodgkin lymphoma1 trial
• Melanoma1 trial
• and 1 more

Phase

• Phase 310 trials
• Phase 2/32 trials
• Phase 42 trials
• Phase 21 trial

Status

• Recruiting9 trials
• Completed6 trials
• Active, not recruiting3 trials
• Terminated1 trial

Lead sponsor

• University College, London3 trials
• Hoffmann-La Roche2 trials
• Institute of Cancer Research, United Kingdom2 trials
• Janssen Research & Development, LLC2 trials
• University Hospital Southampton NHS Foundation Trust2 trials
• and 8 more

Running trials

• Recruiting

  A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  NCT07218341· Phase 4· Eli Lilly and Company· Source

  Contact: David Allsup (principal investigator)

• Recruiting

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· Phase 3· Daiichi Sankyo· Source

• Recruiting

  A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  NCT06750094· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  NCT06662786· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

  NCT06440174· University Hospital Southampton NHS Foundation Trust· Source

• Recruiting

  RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure

  NCT05568069· University Hospital Southampton NHS Foundation Trust· Source

  Contact: Antony Renjith

• Recruiting

  Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

  NCT04685616· Phase 3· University College, London· Source

  Contact: Russell Patmore

• Active, not recruiting

  A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

  NCT05091567· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Renal Adjuvant MultiPle Arm Randomised Trial

  NCT03288532· Phase 3· University College, London· Source

  Contact: Anthony Maraveyas (principal investigator)

• Active, not recruiting

  Stereotactic Body Radiotherapy for the Treatment of OPD

  NCT03256981· Phase 2/3· Institute of Cancer Research, United Kingdom· Source

• Recruiting

  The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

  NCT03562169· Phase 3· University of Leeds· Source

  Contact: Senthilkumar Durairaj

• Active, not recruiting

  Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer

  NCT01566240· Phase 3· University College, London· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Colorectal cancer2 recruiting
• Gastric and oesophageal cancer2 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Heart failure1 recruiting
• Hodgkin lymphoma1 recruiting
• Kidney cancer1 recruiting
• Multiple myeloma1 recruiting

Closed trials

• Completed

  Azithromycin and Oesophageal Function in Respiratory Disease

  NCT05469555· Hull University Teaching Hospitals NHS Trust· Source

• Terminated

  CD8 Minibody Repeatability Study

  NCT05744128· Phase 2· ImaginAb, Inc.· Source

• Completed

  A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer

  NCT04619797· Phase 2/3· Hoffmann-La Roche· Source

• Completed

  Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

  NCT04472429· Phase 3· Incyte Corporation· Source

• Completed

  Benralizumab Exacerbation Study

  NCT04102800· Phase 4· NHS Greater Glasgow and Clyde· Source

• Completed

  A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation

  NCT02444338· University Medical Center Goettingen· Source

• Completed

  Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours

  NCT01726374· Phase 3· Institute of Cancer Research, United Kingdom· Source